Replimune Group Prices Public Offering at $13 Per Share

Replimune Group, Inc. announced a public offering of 6.923 million common shares at $13.00 each, expecting to close on November 27, 2024. The offering aims for gross proceeds of about $140 million, a significant movement for the stock.

Date: 26-11-2024

AI Rating: 6

Replimune Group, Inc. (REPL) has set the pricing for a public offering of 6.923 million common shares at $13.00 each, with the offering expected to close on November 27, 2024. This move indicates a strategic effort to raise capital, potentially influencing the company’s stock price positively if investors view the offering favorably.

The company also announced the pricing of pre-funded warrants for purchasing 3.846 million additional common shares at a slightly lower price of $12.9999 per warrant. This pricing reflects a close alignment with the common share price, which can be seen as a supportive strategy to attract investors.

Replimune has granted its underwriter a 30-day option to purchase an additional 1.615 million common shares, potentially increasing the total funds raised. The expected gross proceeds from the offering are approximately $140 million, which provides substantial liquidity for the company to invest in potential growth opportunities or manage operational costs.

Stocks: REPL